These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14659662)

  • 1. LightCycler gyrA mutation assay (GAMA) identifies heterogeneity in GyrA in Salmonella enterica serotypes Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin.
    Walker RA; Skinner JA; Ward LR; Threlfall EJ
    Int J Antimicrob Agents; 2003 Dec; 22(6):622-5. PubMed ID: 14659662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
    Morita M; Ito K; Hirose K; Takahashi H; Shimuta K; Terajima J; Ohnishi M; Harada M; Matsuzaki M; Watanabe H; Izumiya H
    Microbiol Immunol; 2006; 50(9):707-11. PubMed ID: 16985292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
    Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
    Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
    Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.
    Song Y; Roumagnac P; Weill FX; Wain J; Dolecek C; Mazzoni CJ; Holt KE; Achtman M
    J Antimicrob Chemother; 2010 Aug; 65(8):1631-41. PubMed ID: 20511368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
    Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
    Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening method for Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones by PCR-restriction fragment length polymorphism.
    Hirose K; Tamura K; Watanabe H
    Microbiol Immunol; 2003; 47(2):161-5. PubMed ID: 12680720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution melting assay for the detection of gyrA mutations causing quinolone resistance in Salmonella enterica serovars Typhi and Paratyphi.
    Slinger R; Bellfoy D; Desjardins M; Chan F
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):455-8. PubMed ID: 17156963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of high-level ciprofloxacin resistance in Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region?
    Capoor MR; Nair D; Walia NS; Routela RS; Grover SS; Deb M; Aggarwal P; Pillai PK; Bifani PJ
    Epidemiol Infect; 2009 Jun; 137(6):871-8. PubMed ID: 18687156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA sequence analysis of DNA gyrase and DNA topoisomerase IV quinolone resistance-determining regions of Salmonella enterica serovar Typhi and serovar Paratyphi A.
    Hirose K; Hashimoto A; Tamura K; Kawamura Y; Ezaki T; Sagara H; Watanabe H
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3249-52. PubMed ID: 12234852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China.
    Qian H; Cheng S; Liu G; Tan Z; Dong C; Bao J; Hong J; Jin D; Bao C; Gu B
    Sci Rep; 2020 Apr; 10(1):7359. PubMed ID: 32355184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates.
    Walker RA; Saunders N; Lawson AJ; Lindsay EA; Dassama M; Ward LR; Woodward MJ; Davies RH; Liebana E; Threlfall EJ
    J Clin Microbiol; 2001 Apr; 39(4):1443-8. PubMed ID: 11283069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial resistance and molecular subtypes of
    Kong XX; Dong C; Ji H; Wang Y; Bao CC; Huo X; Qian HM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1546-1550. PubMed ID: 29141347
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic diversity of Salmonella enteric serovar typhi and paratyphi in Shenzhen, China from 2002 through 2007.
    Wu W; Wang H; Lu J; Wu J; Chen M; Xu Y; Lu Y
    BMC Microbiol; 2010 Jan; 10():32. PubMed ID: 20113512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations in gyrB using denaturing high performance liquid chromatography (DHPLC) among Salmonella enterica serovar Typhi and Paratyphi A.
    Gupta R; Gaind R; Singh LC; Paglietti B; Deb M; Rubino S; Wain J; Basir SF
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):684-689. PubMed ID: 28938049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.